<DOC>
	<DOCNO>NCT02270281</DOCNO>
	<brief_summary>Although EGDT goal appear achieve , severe derangement organ perfusion detect SDF technique.An abnormal microvascular flow index present 17 % patient ICU . Microcirculatory alteration strong predictor outcome global hemodynamic variables.Improvement microcirculatory dysfunction big challenge clinician . Dexmedetomidine highly selective α2-adrenoreceptor agonist sedation adult critically ill patient exhibit sedative analgesic effect . Recent study suggest dexmedetomidine restore adrenergic vasoconstrictor responsiveness septic shock , prevents alteration pain rat model intestinal microcirculation Induced surgical stress，even reduce mortality endotoxemic rat patient severe sepsis . The investigator conduct clinical trial investigate effect dexmedetomidine microcirculatory dysfunction early septic shock patient relative stable hemodynamics . thirty patient septic shock enrol . After sufficient fluid resuscitation hemodynamic stabilization 24 hour , patient require sedation receive continuous infusion two dose dexmedetomidine ( infusion rate 0.3 0.6 mcg/kg/h ) 1 hour need . The sublingual microcirculation serum level catecholamine examine preset time point . The vital sign , hemodynamic parameter record analyze .</brief_summary>
	<brief_title>The Effect Dexmedetomidine Microcirculation Septic Shock</brief_title>
	<detailed_description>The enrolled thirty patient septic shock treat accord SSC guideline . After sufficient fluid resuscitation hemodynamic stabilization 24 hour , initial sublingual microcirculation , serum level catecholamine hemodynamic variable examine beseline , patient receive continuous infusion dexmedetomidine ( infusion rate 0.3 mcg/kg/h ) one hour , parameter examine . Dose escalation 0.6 mcg/kg/h , examination repeated.At last , stop continuous infusion dexmedetomidine two hour , parameter record . Systemic pulmonary hemodynamic variable , microcirculatory flow variable , blood gas , vasoactive agent requirement determine baseline dexmedetomidine administration</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ICU patient require sedation Patients diagnosis septic shock meet septic shock criterion accord definition Surviving Sepsis Campaign Patient 's hemodynamic status stable adequate management Patient understood inform consent agree participate study Patient old 18 year old pronounce cardiac dysfunction ( i.e. , cardiac index [ CI ] ≤ 2.2 L/min/m2 presence pulmonary artery occlusion pressure [ PAOP ] &gt; 18 mm Hg ) significant valvular heart disease onset septic shock 24h enrollment APACHE II &gt; 30 enrollment patient pregnant allergic history dexmedetomidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>